AbbVie stock surged early Friday after beating fourth-quarter expectations, largely on the back of its immunology drugs.
A well-known YouTuber has hinted at his interest in purchasing TikTok, making an already-complicated situation even murkier.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback